Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs through the Part D Senior Savings Model for the 2021 plan year, the Centers for Medicare & Medicaid Services said yesterday.

Announced in March, the five-year model will require participating plans to limit cost sharing for a 30-day supply of insulin to no more than $35. CMS estimates beneficiaries in the plans could save an average $446 (66%) in out-of-pocket costs for insulin, funded in part by manufacturer discounts. Part D sponsors that applied must submit their calendar year 2021 plan benefits to CMS by June 1. CMS expects to release CY 2021 premiums and costs for specific Medicare plans in September, including final information on the model.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services has created an Office of Burden Reduction and Health Informatics to build on its Patients over Paperwork…
Headline
Hospitalization rates for COVID-19 were nearly four times higher for black, and two times higher for Hispanic, Medicare beneficiaries than for white Medicare…
Headline
Beginning July 6, both traditional Medicare and Medicare Advantage plans will cover diagnostic COVID-19 laboratory tests for nursing home residents and…
Headline
The Medicare Payment Advisory Commission yesterday issued its June report to Congress on refinements to Medicare payment systems and issues affecting the…
Headline
The Centers for Medicare & Medicaid Services yesterday released a fact sheet for state and local governments seeking Medicare, Medicaid or Children’s…
Headline
The Government Accountability Office today named three new members to the Medicare Payment Advisory Commission through April 2023. They are: Wayne…